Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting REDWOOD CITY, CALIF, May 17, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that the Company would be presenting four posters at the upcoming annual meeting of the American Thoracic...

P2D Bioscience Receives NIH Funding to Develop Drugs for Lung Disease CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Jul 19, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, announced today that the company has received a $320,000 grant from...

Nobel Prize Laureate Dr. Peter Agre Awarded With the "Annual Prize for Outstanding Contribution to Lung Research" by Will Rogers Institute BEVERLY HILLS, CA--(Marketwire - December 11, 2008) - Nobel laureate Dr. Peter Agre was awarded the "Annual Prize for Outstanding Contribution to Lung Research" at the annual meeting for the Will...